|
I. CAPITAL STOCK
|
9 Months Ended |
|---|---|
|
Sep. 30, 2014
|
|
| Stockholders' Equity Note [Abstract] | |
| NOTE I - CAPITAL STOCK |
The Company has authorized 15,000,000 shares of preferred stock (designated and undesignated), with a par value of $.001 per share. The Company has designated 215 shares as Series A preferred stock and 538 shares as Series B preferred stock. At both September 30, 2014 and December 31, 2013, there were 185 shares of Series A and 55 shares of Series B outstanding.
The Company has authorized 190,000,000 shares of common stock with a par value of $.001 per share. As of both September 30, 2014 and December 31, 2013 the Company had 125,035,612 common shares issued and outstanding. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|